Generics 13

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Oxybutynin manufacturers

13 products found

Filters

13 products found

oxybutynin

Oral solution 2.5 mg/5 ml, 5 mg/5 ml - 150 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Registered in
United Kingdom
Available for
Technology transfer
Manufacturer #15507

A privately owned CDMA service provider that is aimed to benefit people from its pharmaceutical solutions. They have dosages in the form of oral liquid and likewise. The company is one of the pioneers of having high-value credentials in the development, manufacturing, and commercialization of healthcare products.

Manufacturer usually replies in 8 days

oxybutynin

Patch 36 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #535
This European pharmaceutical company has been operating for several decades, focusing on improving patient health and quality of life through innovative solutions. They specialize in developing Rx products, particularly in the areas of pain management, respiratory conditions, autoimmune diseases, and urogynecology. Their commitment to research and development involves collaborations with scientific partners to create new solutions. Their product portfolio includes oral and injectable dosage forms, and they hold GMP approvals in both the EU and the US. The company's dedication to a positive work environment is evident in their Great Place to Work certification. They actively seek collaborations and licensing agreements with other pharmaceutical and biotechnology companies, demonstrating their commitment to innovation and growth.

Manufacturer usually replies in nan days

oxybutynin

Tablets 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17783
It is a pharmaceutical company that began operations in the 2000s in North America and sells a wide selection of generic pharmaceuticals while continuing to expand its portfolio. They try to deliver accessible solutions for patient safety through continuing innovation such as simpler packaging and important safety features. They are laser-focused on developing cutting-edge solutions to ensure that patients have access to high-quality pharmaceuticals.

Manufacturer usually replies in 9 days

Want to see all 13 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Oxybutynin is a medication used to treat overactive bladder. Suppliers market it as oxybutynin oral tablets, transdermal patches, topical gels and it is available as immediate and delayed-release formulations. The drug was first approved for medical use in 1975, and by now has reached widespread use, with over 6 million prescriptions registered yearly in the U.S. alone. Multiple manufacturing companies and drug vendors populate the global oxybutynin market, including major suppliers such as Sanofi-Aventis, Mylan, Accord Healthcare, and many others. Suppliers market both generic and trade name oxybutynin medications. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. The retail prices per 60 (5mg) tablets of oxybutynin fall into an approximate range of 7.50 EUR to 10.00 EUR.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible